Difference between revisions of "Corona Vaccins First Dose Efficacy"
From Tech
Jump to navigationJump to search(2 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765?articleTools=true#page=7 Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting] |
[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765?articleTools=true#page=7 Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting] |
||
− | [[File:Screenshot 2021-07-11 at 12-37-30 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting - NEJMoa2101765.png|x200px |
+ | [[File:Screenshot 2021-07-11 at 12-37-30 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting - NEJMoa2101765.png|x200px]] |
=Moderna= |
=Moderna= |
||
− | [https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
+ | [https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
− | [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|x200px |
+ | [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|x200px]] |
=AstraZeneca= |
=AstraZeneca= |
||
⚫ | |||
⚫ | |||
+ | |||
[[File:Screenshot 2021-07-11 at 13-07-32 Public Assessment Report - UKPAR COVID 19 Vaccine AstraZeneca 23 02 2021 pdf.png|x200px]] |
[[File:Screenshot 2021-07-11 at 13-07-32 Public Assessment Report - UKPAR COVID 19 Vaccine AstraZeneca 23 02 2021 pdf.png|x200px]] |
||
⚫ | |||
+ | =Janssen= |
||
⚫ | |||
+ | [https://www.nejm.org/doi/full/10.1056/NEJMoa2101544 Cumulative Incidence of Covid-19 with Onset at Least 1 Day after Vaccination and Vaccine Efficacy over Time.] |
||
+ | |||
+ | [[File:Screenshot 2021-07-11 at 14-04-04 Safety and Efficacy of Single-Dose Ad26 COV2 S Vaccine against Covid-19 NEJM.png|x200px]] |
||
+ | |||
+ | =See Also= |
||
+ | * [[Vaccins]] |
||
+ | * [[Corona]] |